Autologous adipose-derived mesenchymal stem cells Therapy(Regeneration)

N/A

Report date: 2025/10/09 20:00:09

Base Information

Drug NameAutologous adipose-derived mesenchymal stem cells Therapy(Regeneration)

Drug Alias Nameautologous ADSC stem cells(Regeneration)autologous ADSC(Regeneration)RB-ADSC

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesRegeneration Biomedical Inc

China Registration ClassN/A

Develop Information

Active CompaniesRegeneration Biomedical Inc

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A